Related Experiment Videos

Rationale for the combination therapy of 5FU and CDDP

N Saijo¹, Y Sugirnoto

¹Pharmacology Division, National Cancer Center Research Institute, Tokyo.

Advances in Experimental Medicine and Biology

|January 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402).

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation.

British journal of cancer·2011

Cross-resistance to antineoplastic agents in a human small-cell lung-cancer subline resistant to okadaic Acid.

Oncology reports·2011

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.

Oncogene·2011

A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606).

British journal of cancer·2010

See all related articles